World Successfully-known Legislation Agency Grant & Eisenhofer Files Class Movement Lawsuit In opposition to Canadian Banks CIBC and RBC Alleging Unlawful Stock Market Manipulation of Quantum BioPharma Shares
Article jabber material
TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class motion lawsuit alleging that traders in Quantum BioPharma had been the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., previously identified as FSD Pharma Inc., had been vastly and materially harmed.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to be taught the latest news in your metropolis and at some level of Canada.
- Uncommon articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, and others.
- Day-to-day jabber material from Financial Cases, the sphere’s main world alternate e-newsletter.
- Limitless on-line get right of entry to to be taught articles from Financial Put up, National Put up and 15 news internet sites at some level of Canada with one fable.
- National Put up ePaper, an electronic reproduction of the print edition to stare on any instrument, part and reveal on.
- Day-to-day puzzles, including the New York Cases Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to be taught the latest news in your metropolis and at some level of Canada.
- Uncommon articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman and others.
- Day-to-day jabber material from Financial Cases, the sphere’s main world alternate e-newsletter.
- Limitless on-line get right of entry to to be taught articles from Financial Put up, National Put up and 15 news internet sites at some level of Canada with one fable.
- National Put up ePaper, an electronic reproduction of the print edition to stare on any instrument, part and reveal on.
- Day-to-day puzzles, including the New York Cases Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Function an fable or imprint in to proceed alongside with your finding out skills.
- Access articles from at some level of Canada with one fable.
- Fragment your solutions and join the conversation in the feedback.
- Ride extra articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Function an fable or imprint in to proceed alongside with your finding out skills.
- Access articles from at some level of Canada with one fable
- Fragment your solutions and join the conversation in the feedback
- Ride extra articles per month
- Get email updates from your favourite authors
Ticket In or Function an Story
or
Article jabber material
Article jabber material
A link to this criticism may perchance additionally even be found here.
Article jabber material
Article jabber material
By signing up you consent to catch the above newsletter from Postmedia Community Inc.
Article jabber material
Quantum Biopharma intends to search records from appointment as a lead plaintiff in this class motion in allege to again in conserving its shareholders.
Article jabber material
Article jabber material
Quantum Biopharma Ltd. has renewed the products and services of LWM for one month starting December 22, 2025.
Article jabber material
About Quantum BioPharma Ltd.
Article jabber material
Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company devoted to constructing a portfolio of modern resources and biotech alternate options for the medication of fascinating neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in varied phases of development. Via its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum BioPharma is targeted on the learn and development of its lead compound, Lucid-MS. Lucid-MS is a patented modern chemical entity proven to cease and reverse myelin degradation, the underlying mechanism of a few sclerosis, in preclinical fashions. Quantum BioPharma invented unbuzzd™ and spun out its OTC model to an organization, Celly Vitamin Corp. (“Celly Vitamin”), now Unbuzzd Wellness Inc., led by alternate veterans. Quantum BioPharma retains possession of 19.86% as of September 30, 2025 of Unbuzzd Wellness Inc. at www.unbuzzd.com. The agreement with Unbuzzd Wellness Inc. additionally contains royalty payments of seven% of gross sales from unbuzzd™ till payments to Quantum BioPharma total $250 million. As soon as $250 million is reached, the royalty drops to three% in perpetuity. Quantum BioPharma retains 100% of the rights to map same merchandise or alternative formulations particularly for pharmaceutical and medical makes expend of. Quantum BioPharma maintains a portfolio of strategic investments by its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or business property. For added records search recommendation from www.quantumbiopharma.com.
Article jabber material
Article jabber material
Forward-Searching Files
Article jabber material
This press launch contains certain “forward-having a stare statements” at some level of the that job of applicable securities regulation. Any statements that explain or involve discussions with recognize to predictions, expectations, beliefs, plans, desires, assumptions or future events or performance (assuredly, nonetheless not continuously, identified by words or phrases a lot like “believes”, “hopes”, “alleges”, “pending”, “extra”, or variations of such words and phrases or statements that certain actions events or results “may perchance additionally”, “may perchance”, “which”, or “will” and same expressions) are not statements of ancient fact and ought to be forward-having a stare statements. Forward-having a stare records herein contains, nonetheless just isn’t restricted to, statements regarding: the Firm’s ongoing litigation in opposition to predominant monetary institutions; the aptitude or judgment payment; expectations regarding whistleblower submissions and associated rewards; persisted market integrity initiatives; future alternate performance and probably acquisitions.
Article jabber material
In making the forward-having a stare statements in this news launch, the Firm has utilized several discipline matter assumptions, including with out limitation: the flexibility to invent and validate whistleblower proof; the timing and of apt complaints; resolution of ongoing litigation on beneficial terms, availability and sufficiency of litigation funding; persisted regulatory compliance and market stability for the Firm’s operations.
